Germany – Pharmaceutical products – Arzneimittelrahmenrabattvertrag gemäß § 130c Absatz 1 des Fünften Sozialgesetzbuchs
DAK-Gesundheit tender for Healthcare & Medical, worth €1, published in April 2025.
Sign-up only
See who won, the status and the award date.
A free account shows the winner. The status and the award date come with the US$19 3-day pass or a subscription.
Sign up free →Free account · cancel anytime
Contract description
Germany – Pharmaceutical products – Arzneimittelrahmenrabattvertrag gemäß § 130c Absatz 1 des Fünften Sozialgesetzbuchs - Aimovig (Wirkstoff: Erenumab), ATC N02CD01
Other tenders · DAK-Gesundheit
The buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.
Winners and award dates are hidden on the public page. Sign up free to see them →
- ocds-ted-413759-2026-8Not disclosed16 Feb 2024 Healthcare
- ocds-ted-413759-2026-7Not disclosed16 Feb 2024 Healthcare
- ocds-ted-413759-2026-6Not disclosed16 Feb 2024 Healthcare
Sign-up only
See who won, the status and the award date.
A free account shows the winner. The status and the award date come with the US$19 3-day pass or a subscription.
Sign up free →Free account · cancel anytime